MYO3A

myosin IIIA

Summary

The protein encoded by this gene belongs to the myosin superfamily. Myosins are actin-dependent motor proteins and are categorized into conventional myosins (class II) and unconventional myosins (classes I and III through XV) based on their variable C-terminal cargo-binding domains. Class III myosins, such as this one, have a kinase domain N-terminal to the conserved N-terminal motor domains and are expressed in photoreceptors. The protein encoded by this gene plays an important role in hearing in humans. Three different recessive, loss of function mutations in the encoded protein have been shown to cause nonsyndromic progressive hearing loss. Expression of this gene is highly restricted, with the strongest expression in retina and cochlea. [provided by RefSeq, Jul 2008]

Known Variants671 total

rsidPosition (GRCh37)AllelesClassClinVar
rs18455414810:26,223,050G/A—uncertain significance
rs88604691510:26,223,060G/C—uncertain significance
rs707308410:26,223,147A/G—likely benign
rs18859796710:26,223,173C/G—likely benign
rs92941149510:26,223,216G/A—uncertain significance
rs707322410:26,223,230A/G—likely benign
rs183589228310:26,223,253C/T—uncertain significance
rs88604691710:26,224,727A/G—uncertain significance
rs56451909210:26,224,740A/G—uncertain significance
rs18991209810:26,224,747A/G—uncertain significance
rs1012829810:26,224,759G/A—benign
rs94668810:26,226,918C/Gupstream gene variant—
rs1745009210:26,240,944C/T—likely benign
rs1101487510:26,241,025T/A—benign
rs72750459310:26,241,040A/G—uncertain significance
rs101564998210:26,241,064A/G—uncertain significance
rs75134765210:26,241,074A/T—uncertain significance
rs77116362910:26,241,122G/A—uncertain significance
rs249170781910:26,241,142G/A—uncertain significance
rs19959724910:26,241,151G/T—uncertain significance
rs14451844710:26,241,152T/C—uncertain significance
rs76486119410:26,241,154T/C—likely benign
rs249170823110:26,241,172C/T—pathogenic
rs14400898410:26,241,191T/A—uncertain significance
rs119102458210:26,241,193C/G—uncertain significance
rs20166892010:26,241,207C/T—uncertain significance
rs77786649510:26,241,208G/A—likely pathogenic
rs36980754910:26,241,210A/G—uncertain significance
rs74937187110:26,241,215A/T—likely benign
rs792369110:26,241,456G/A—benign
rs1225254610:26,243,603G/T—benign
rs1224731810:26,243,710A/C—benign
rs14651180010:26,243,804A/C—uncertain significance
rs13995827510:26,243,811C/T—conflicting classifications of pathogenicity
rs56939291610:26,243,836A/C—uncertain significance
rs75734859010:26,243,844A/T—uncertain significance
rs37278289310:26,243,853T/G—likely benign
rs102983270610:26,243,859C/A—uncertain significance
rs123222901010:26,243,864A/C—uncertain significance
rs37701513210:26,243,867T/G—uncertain significance
rs181958206510:26,243,877C/A—uncertain significance
rs77035995410:26,243,884A/T—uncertain significance
rs147126092210:26,243,888A/G—uncertain significance
rs75921890010:26,243,892T/C—likely benign
rs77524409910:26,243,905G/T—uncertain significance
rs97748108810:26,243,909A/G—uncertain significance
rs128205109010:26,243,919G/T—uncertain significance
rs76052510210:26,243,922G/A—likely benign
rs37011172410:26,243,950G/C—likely benign
rs154670010:26,244,089T/A—benign
rs154669910:26,244,096G/T—benign
rs154669810:26,244,146A/G—benign
rs7866665410:26,244,224T/A—benign
rs11339612010:26,285,100G/A—benign
rs5911854610:26,285,132C/T—likely benign
rs11143012910:26,285,136T/C—benign
rs7941737110:26,285,248A/G—benign
rs4127990610:26,285,287A/C—benign
rs213090031210:26,285,408T/G—uncertain significance
rs128605860710:26,285,413G/C—likely benign
rs213090049310:26,285,426G/T—uncertain significance
rs88604691810:26,285,447T/C—uncertain significance
rs75655789010:26,285,489C/T—uncertain significance
rs116491006210:26,285,508A/C—uncertain significance
rs7878883310:26,285,840T/G—likely benign
rs11469384010:26,285,846T/C—likely benign
rs19193890210:26,286,070A/G—likely benign
rs249208769810:26,286,082T/C—likely benign
rs14030121810:26,286,103C/T—conflicting classifications of pathogenicity
rs18959583210:26,286,105T/G—conflicting classifications of pathogenicity
rs77323398510:26,286,136G/A—uncertain significance
rs141262464310:26,286,151T/C—likely benign
rs20087971310:26,286,158C/T—uncertain significance
rs1225711910:26,286,159G/T—benign
rs14892323710:26,286,166G/A—uncertain significance
rs184051352010:26,286,189T/C—likely pathogenic
rs92739214610:26,286,206G/A—likely benign
rs7500256610:26,286,223A/T—likely benign
rs791170010:26,286,367G/A—benign
rs11629405910:26,286,423C/T—benign
rs791184710:26,286,424G/A—likely benign
rs7737214410:26,286,466G/A—likely benign
rs7926674310:26,286,470G/A—likely benign
rs1692652310:26,294,828G/Aintron variant—
rs11723874010:26,305,733T/C—likely benign
rs184200828910:26,305,734T/C—uncertain significance
rs134619795110:26,305,771T/G—uncertain significance
rs3396874810:26,305,773C/T—likely benign
rs14405378910:26,305,775C/T—conflicting classifications of pathogenicity
rs57422041610:26,305,782G/A—likely benign
rs14834953210:26,305,786G/T—conflicting classifications of pathogenicity
rs137941343610:26,305,807G/A—likely benign
rs72750467110:26,305,808T/C—uncertain significance
rs20038166010:26,305,828C/T—uncertain significance
rs20218984410:26,305,829A/T—conflicting classifications of pathogenicity
rs249235789010:26,305,835A/T—likely benign
rs14739944010:26,310,174C/T—likely benign
rs4131463310:26,310,209C/T—benign
rs5607727710:26,310,403C/T—benign
rs4131463110:26,310,404A/G—benign

Showing 100 of 671 variants. Use the SNP search for the full list.

Gene information from NCBI Gene. Variant classifications from ClinVar.